| Disease Subtype(s) |
HCT Disease Inserts Required |
Cellular Therapy Disease Inserts Required |
MDS with Defining Genetic Abnormalities
- MDS with low blasts and isolated 5q deletion (MDS-5q) (66)
- MDS with low blasts and SF3B1 mutation (MDS-SF3B1) (1411)
- MDS with low blasts and ring sideroblasts (>=15% ring sideroblasts and wild type SF3B1) (1412)
- MDS with biallelic TP53 inactivation (MDS-biTP53) (1413)
MDS, Morphically Defined
- MDS, with low blasts (MDS-LB; <5% BM, <2%PB) (1414)
- MDS, hypoplastic (MDS-h) <=25% cellularity by age (1415)
- MDS with increased blasts (MDS-IB1) (61)
- MDS with increased blasts (MDS-IB2) (62)
- MDS with fibrosis (MDS-f) (1416)
Childhood Myelodysplastic Neoplasms (MDS)
- Childhood MDS with low blasts, hypocellular (68)
- Childhood MDS with low blasts, not otherwise specified (1417)
- Childhood MDS with increased blasts (1418)
Myelodysplastic/Myeloproliferative Neoplasms
- Chronic myelomonocytic leukemia (CMML), myelodysplastic (54)
- Chronic myelomonocytic leukemia (CMML), myeloproliferative (1419)
- Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis (1452)
- MDS/MPN with ring siderobloasts (>=15% ring sideroblasts and wild type SF3B1) and thrombocytosis (1420)
|
Forms 2014 & 2114 |
No disease inserts required |
- Juvenile myelomonocytic leukemia (JMML/JCML)(no evidence of Ph1 or BCR/ABL) (36)
|
Forms 2015 & 2115 |
- Myelodysplastic/myeloproliferative neoplasm with neutrophilia (1440)
- Myelodysplastic syndrome/myeloproliferative neoplasm, NOS (69)
|
Forms 2014 & 2114 |
Last modified:
May 29, 2024
